Clinical Trial Update: Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating dupilumab to prevent asthma exacerbations in urban children and adolescents; the study is sponsored by NIAID and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | Phase 2 | Status: ACTIVE_NOT_RECRUITING